|
|
||||||||
Radiology, Vol 183, 59-64, Copyright © 1992 by Radiological Society of North America
ARTICLES |
G Schuhmann-Giampieri, H Schmitt-Willich, WR Press, C Negishi, HJ Weinmann and U Speck
Institute of Contrast Media Research, Schering AG Berlin/Bergkamen, Germany.
Gadolinium diethylenetriaminepentaacetic acid (DTPA) covalently linked to the lipophilic ethoxybenzyl moiety (Gd-EOB-DTPA) was designed for use as a contrast agent in hepatobiliary magnetic resonance imaging. With T1 relaxivity values of 8.7 L/mmol.second in plasma and 16.6 L/mmol.second in rat liver tissue and a median lethal dose of 10 mmol/kg when administered intravenously in mice and rats, Gd-EOB-DTPA has a fairly high margin of safety. In rats and monkeys, biodistribution studies performed 7 days after administration of 0.25 mmol/kg revealed very little retention of gadolinium (less than 1%) in the tissues, indicating complete elimination via renal and biliary excretion. Biliary excretion was inhibited by coadministration of sulfobromophthalein, indicating the involvement of a carrier-mediated transport system based on the enzyme glutathione-S-transferase. In rats, the biliary transport maximum was 5 mumol gadolinium/min.kg. High T1 relaxivity of Gd-EOB-DTPA in rat liver in vivo can be explained by transient interaction with intracellular components and by increased microviscosity inside the hepatocyte.
This article has been cited by other articles:
![]() |
A. Huppertz, S. Haraida, A. Kraus, C. J. Zech, J. Scheidler, J. Breuer, T. K. Helmberger, and M. F. Reiser Enhancement of Focal Liver Lesions at Gadoxetic Acid-enhanced MR Imaging: Correlation with Histopathologic Findings and Spiral CT--Initial Observations Radiology, February 1, 2005; 234(2): 468 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Huppertz, T. Balzer, A. Blakeborough, J. Breuer, A. Giovagnoni, G. Heinz-Peer, M. Laniado, R. M. Manfredi, D. G. Mathieu, D. Mueller, et al. Improved Detection of Focal Liver Lesions at MR Imaging: Multicenter Comparison of Gadoxetic Acid-enhanced MR Images with Intraoperative Findings Radiology, January 1, 2004; 230(1): 266 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kobayashi, T. Saga, S. Kawamoto, N. Sato, A. Hiraga, T. Ishimori, J. Konishi, K. Togashi, and M. W. Brechbiel Dynamic Micro-Magnetic Resonance Imaging of Liver Micrometastasis in Mice with a Novel Liver Macromolecular Magnetic Resonance Contrast Agent DAB-Am64-(1B4M-Gd)64 Cancer Res., July 1, 2001; 61(13): 4966 - 4970. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. van Montfoort, B. Stieger, D. K. F. Meijer, H.-J. Weinmann, P. J. Meier, and K. E. Fattinger Hepatic Uptake of the Magnetic Resonance Imaging Contrast Agent Gadoxetate by the Organic Anion Transporting Polypeptide Oatp1 J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 153 - 157. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |